Diego Fernando Salcedo Miranda

@docpinoAI @jsenior64 Jajaj excelente comentario! Deacuerdo!

Idea incómoda #1: El médico que asume que una máquina puede reemplazarlo, probablemente ya está ejerciendo como una, y esta debería efectivamente reemplazarlo.

Pulmonary large-cell neuroendocrine carcinoma (LCNEC) is a rare and aggressive lung cancer with clinical/biological heterogeneity. Management is largely extrapolated from other lung cancer paradigms. Check out a recent review on this challenging disease. bit.ly/4bFikdp

2025: Summary of Ttx for NSCLC in 3 slides ➕: IO is SoC in early stage ➖: multiple « me too » agents but cost of drugs is ⬆️ and access is ⬇️ worldwide ✏️: optimal Ttx duration with IO or TT ✏️: access to TT for rare 🧬altertions ✏️: role of ADCs? We need more Academic trials!

Lung Cancer in Nonsmoking Individuals Randomized clinical trial: ja.ma/3L2hpIw Editorial: ja.ma/4hlEZw6 Review: ja.ma/42O99Cb Patient Page: ja.ma/4hnqxUr Podcast: ja.ma/48FkBDU

Asegurate que tu Manejo de patologia Toracica sea por Un Cirujano de Torax Calificado

We are thrilled to welcome internationally renowned cardiovascular surgeon Juan Pablo Umaña, M.D., to @UMiamiMedicine and UHealth as our new Chief of Cardiothoracic Surgery! ❤️ Dr. Umaña is a global leader in aortic and mitral valve repair, the founder of the Latin-American Cardiovascular Surgery Conference, and the visionary behind Latin America's most extensive heart valve repair program. His arrival marks a transformative moment for our cardiovascular care — bringing innovation, leadership, and a deep commitment to patient-centered excellence. From training the next generation of surgeons to advancing minimally invasive techniques, Dr. Umaña is poised to lead us into a new era of care — for South Florida and beyond. 🙌 Learn more: loom.ly/g3J5b7w

Advances in molecular pathology and therapy of non-small cell lung cancer 💫An exceptionally comprehensive review (72 pages 👀) Algorithms👇 nature.com/articles/s4139…

Complex Esophageal Reconstruction for patients who need #esophagealReplacement as seen in the @annalsthorsurg pubmed.ncbi.nlm.nih.gov/40274211/

🫁 Summary of immunotherapies early stage NSCLC 1/3 ⭐️ Key clinical data as of June 2025 ※ #ASCO25 data included.

About lung cancer! …

So important to remember - continuation of pemetrexed maintenance on the #FLAURA2 likely is required to derive benefit! @JuliaRotow @asco #ASCO25 @EGFRResisters @DFEGFRcenter #LCSM

Excited for the #LCSM session today at #ASCO25! 🚨 Here’s the latest treatment algorithm for advanced/metastatic #NSCLC 👇 How will it change after today?🔥 Can’t wait to see where new agents & trial data may fit in! @LungCancerRx @HemOncFellows @Oncoalert @OncBrothers @n8pennell @SuyogCancer @HemOncFellows @GlopesMd @HHorinouchi @APassaroMD @lungoncdoc @NarjustFlorezMD @DevikaDasMD @DrJNaidoo @NaglaAKarimMD @Lung_Cancers @DrSanjayPopat @tnewsomdavis @Tony_Calles @ns_chd @BalazsHalmosMD @ipreeshagul @BoschBarrera @FordePatrick @LuisRaezMD @COlazagasti @OncNewsCentral @imedverse @Latinamd @Larvol @ChristianRolfo @AboutLungCancer @ilyassahinMD @AEACaP @acmoorephd @DipeshUpretyMD @Alfdoc2 @g_mountzios @marinagarassino @DrRiyazShah @StephenVLiu @weoncologists @M_Torasawa @FawziAbuRous @rajatthawani @thenasheffect @drshieldsmd @BrunaPellini @AnaVManana

#ASCO25 @JuliaRotow @DanaFarber elegantly presents the case for #osimertinib Monotherapy over combination strategies (FLAURA2, MARIPOSA) ▶️ Reserving combination for higher risk pts ▶️ Maximixing each therapy in sequential approach ▶️ Shared decision w patients @EGFRResisters

Preoperative chemoimmunotherapy followed by surgery and postoperative immunotherapy in lung cancer: limited compliance for all planned therapy #ASCO25 ⁦@OncoAlert⁩

Thymic carcinoma !!! Be Careful ...

Esofaguectomia de calidad

Indicaciones de Manejo Quirurgico Por Cirugia de Torax en Pacientes con Neumotorax espontaneo !

Metastasectomia en Cancer de Colon y Recto... Aun sigue Teniendo un Campo Muy grande en la cirugia de torax (Sincronico y Metacronico)!!!

Training the nursing department on the pleural drainage system is essential to maintain safe medical care.

Me: It is not about chemotherapy vs surgery, it is about focusing the patient on the best scenario of clinical trials, depending on the characteristics of the disease. Surgeons will have to fight so that the surgical technique has fewer side effects and survives medical therapy